HPV-6-targeting immunotherapeutic vaccine INO-3106
Term · Oncology and biomedicine · MLC-T-ONC-014196
A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and antineoplastic activities. Administered via intramuscular electroporation, HPV-6-targeting immunotherapeutic vaccine INO-3106 expresses the HPV-6 E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells that are expressing those proteins, resulting in tumor cell lysis. HPV-6 infections are associated with aerodigestive malignancies.
| Identifier | MLC-T-ONC-014196 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | HPV-6-targeting immunotherapeutic INO-3106; HPV-6 E6/E7 DNA vaccine INO-3106 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014196",
"term": "HPV-6-targeting immunotherapeutic vaccine INO-3106",
"field": "Oncology and biomedicine",
"definition": "A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and antineoplastic activities. Administered via intramuscular electroporation, HPV-6-targeting immunotherapeutic vaccine INO-3106 expresses the HPV-6 E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells that are expressing those proteins, resulting in tumor cell lysis. HPV-6 infections are associated with aerodigestive malignancies.",
"synonyms": [
"HPV-6-targeting immunotherapeutic INO-3106",
"HPV-6 E6/E7 DNA vaccine INO-3106"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/hpv-6-targeting-immunotherapeutic-vaccine-ino-3106/"
}
Record 8,671 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.